COVID-19 Health Care Funding, Regulatory Waivers, and the False Claims Act: Protecting Your Business Today from Agency Enforcement and Whistle Blower Actions Tomorrow

Click here to access a PDF of the slides.

To combat the COVID-19 pandemic, Congress has passed the CARES Act as well as other stimulus legislation authorizing many different funding streams for which a variety of health care entities are eligible, e.g., through the Public Health and Social Services Emergency Fund and the Paycheck Protection Program. Though these funds provide necessary assistance throughout the industry, they also are subject to a number of terms and conditions and reporting obligations, will be a target of audits, and come with substantial False Claims Act (FCA) enforcement risk. In addition to funding, HHS has granted several Section 1135 waivers, such as with respect to the Stark Law, other regulatory flexibilities, and modifications to reimbursement. These changes offer providers and suppliers more latitude given the challenges posed by the pandemic, but compliance with the new guidance is imperative to mitigate FCA enforcement risk and whistleblower actions in the future.   

Join us on Thursday, April 30, 2020 from 2:00 - 3:00 pm EDT for a webinar discussing these risks as well as strategies and best practices you can implement today to mitigate potential FCA actions and other enforcement in the future.